107 related articles for article (PubMed ID: 27835891)
1. Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma.
Song L; Fan Z; Jun N; Benjia L; Zequn L; Xilong W; Zhongming J; Yong H; Xiaohong W; Kai C; Zhenlin Y
Oncotarget; 2016 Dec; 7(51):85163-85175. PubMed ID: 27835891
[TBL] [Abstract][Full Text] [Related]
2. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
3. [Effects of antisense 6 gene on colon cancer cells].
Zhang ZY; Xu KS; Yang GY; Wang JS; Gao Y; Liu YF; Shuai J; Wang JY; Li SY; Shou NH; Niu J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2645-8. PubMed ID: 18162155
[TBL] [Abstract][Full Text] [Related]
4. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
[TBL] [Abstract][Full Text] [Related]
5. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
Li Z; Lin P; Gao C; Peng C; Liu S; Gao H; Wang B; Wang J; Niu J; Niu W
Tumour Biol; 2016 Apr; 37(4):5117-31. PubMed ID: 26547582
[TBL] [Abstract][Full Text] [Related]
6. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
[TBL] [Abstract][Full Text] [Related]
7. Integrin β6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy.
Enyu L; Zhengchuan N; Jiayong W; Benjia L; Qi S; Ruixi Q; Cheng P; Khan AQ; Wei S; Jun N
Tumour Biol; 2015 Aug; 36(8):6541-50. PubMed ID: 25982998
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.
Gao J; Chen H; Yu Y; Song J; Song H; Su X; Li W; Tong X; Qian W; Wang H; Dai J; Guo Y
Biomaterials; 2013 Dec; 34(38):10084-98. PubMed ID: 24060417
[TBL] [Abstract][Full Text] [Related]
9. c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.
Li Y; Wang J; Gao X; Han W; Zheng Y; Xu H; Zhang C; He Q; Zhang L; Li Z; Zhou D
PLoS One; 2014; 9(11):e113186. PubMed ID: 25427200
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer.
Bäumer S; Bäumer N; Appel N; Terheyden L; Fremerey J; Schelhaas S; Wardelmann E; Buchholz F; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Mar; 21(6):1383-94. PubMed ID: 25589625
[TBL] [Abstract][Full Text] [Related]
11. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
12. Blocking hepatic metastases of colon cancer cells using an shRNA against Rac1 delivered by activatable cell-penetrating peptide.
Bao Y; Guo H; Lu Y; Feng W; Sun X; Tang C; Wang X; Shen M
Oncotarget; 2016 Nov; 7(47):77183-77195. PubMed ID: 27791203
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
14. Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy.
Subramaniam V; Vincent IR; Gilakjan M; Jothy S
Exp Mol Pathol; 2007 Dec; 83(3):332-40. PubMed ID: 17945212
[TBL] [Abstract][Full Text] [Related]
15. Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.
Zhao T; Feng Y; Guo M; Zhang C; Wu Q; Chen J; Guo S; Liu S; Zhou Q; Wang Z; Fan W; Zhang Y; Jia H; Feng Z
J Cell Biochem; 2020 Feb; 121(2):1973-1985. PubMed ID: 31692041
[TBL] [Abstract][Full Text] [Related]
16. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.
Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B
Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.
Bates RC; Bellovin DI; Brown C; Maynard E; Wu B; Kawakatsu H; Sheppard D; Oettgen P; Mercurio AM
J Clin Invest; 2005 Feb; 115(2):339-47. PubMed ID: 15668738
[TBL] [Abstract][Full Text] [Related]
19. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
[TBL] [Abstract][Full Text] [Related]
20. The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells.
Ma Q; Geng Y; Xu W; Wu Y; He F; Shu W; Huang M; Du H; Li M
J Proteome Res; 2010 Jan; 9(1):40-9. PubMed ID: 19621893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
